Quick Takeaways
- GILEAD SCIENCES, INC. filed SCHEDULE 13D/A for ASSEMBLY BIOSCIENCES, INC. Common Stock, par value $0.001 (ASMB).
- Disclosed ownership: 29%.
- Date of event: 08 Aug 2025.
GILEAD SCIENCES, INC. - 08 Aug 2025 SCHEDULE 13D/A Report for ASSEMBLY BIOSCIENCES, INC. Common Stock, par value $0.001 (ASMB)
- Filing Manager
- GILEAD SCIENCES, INC.
- Reporting Manager
- GILEAD SCIENCES, INC.
- Symbol
- ASMB
- Shares outstanding
- 15,535,831 shares
- Disclosed Ownership
- 4,505,391 shares
- Ownership
- 29%
- Form type
- SCHEDULE 13D/A
- Filing time
- 12 Aug 2025, 16:30:07 UTC
- Date of event
- 08 Aug 2025
- Previous filing
- 23 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"GILEAD SCIENCES, INC. disclosed 29% ownership in ASSEMBLY BIOSCIENCES, INC. Common Stock, par value $0.001 (ASMB) on 08 Aug 2025."
What Changed
- Previous schedule filing date: 23 Dec 2024.
- Current filing was accepted on 12 Aug 2025, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 29% | 4,505,391 | 4,505,391 | 0 | /s/ Andrew D. Dickinson | Andrew D. Dickinson, Chief Financial Officer | 0000882095 |